We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News   Sep 23, 2020

 
Phase III Trial of Janssen's COVID-19 Vaccine Launched
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

Product News

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.

READ MORE

Custom Recombinant Monoclonal Antibody Development Service

Product News

AMSBIO announce a new rabbit and mouse recombinant monoclonal antibody development service based upon a revolutionary technology platform.

READ MORE

Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services

Product News

Berlin, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, & Heidelberg Pharma AG, Ladenburg, Germany, today announced that Heidelberg Pharma has signed a Master Service Agreement for the antibodies used in two of their pipeline Antibody Targeted Amanitin Conjugate (ATAC) molecules.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE